Medicine vs Food: The Patient Care Dilemma of Financial Toxicity
Physicians are calling on colleagues to bring up the cost of care and its potential impact when discussing treatment options with patients.
Home
AEs Related to Antibody-Drug Conjugates Most Common in Breast Cancer
Researchers have characterized treatment-related adverse events associated with antibody-drug conjugates in clinical trials.
Decrease Noted in Lung Cancer Cases Over Past 5 Years
The number of new lung cancer cases decreased 11% over the last 5 years.
Metastasis-Directed Therapy Alone May Treat Solitary Prostate Cancer Recurrence
This is the first study to assess the role of metastasis-directed therapy in solitary metastatic oligorecurrent prostate cancer in the absence of systemic therapy.
Most Pivotal Trials of New Drugs Recruit From Low-, Middle-Income Countries
Researchers found that 56% of cancer trials recruited from low- or middle-income countries.
Aprepitant Better Than Desloratadine for TKI-Induced Pruritus
A prospective study compared aprepitant with desloratadine for the relief of treatment-induced pruritus in patients with lung cancer treated with EGFR-TKIs.
Epcoritamab Granted Priority Review for Relapsed/Refractory Large B-Cell Lymphoma
Epcoritamab is designed to bind to CD3 on T cells and CD20 on B cells, inducing T-cell-mediated killing of CD20+ cells.
Clinical Trial: Trastuzumab-Based Combinations in HER2+ Breast Cancer
Researchers are conducting a phase 2 study to compare trastuzumab-based treatment regimens in patients with advanced HER2+ breast cancer.
Clinical Trial: Capecitabine Plus Cemiplimab in HR+ Metastatic Breast Cancer
Researchers are conducting a phase 1 study to test capecitabine in combination with cemiplimab in patients with HR+ metastatic breast cancer.
Clinical Trial: Can ctDNA Guide Treatment in High-Risk, ER+/HER2- Breast Cancer?
Researchers are conducting a phase 2 study to determine if ctDNA can be used to guide treatment in patients with ER+, HER2- breast cancer at high risk of recurrence.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Breast Cancer
Loading... 
Loading...